Explore more publications!
Asia Healthcare Industry Digest
Got News to Share?

Asia Healthcare Industry Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Healthcare Industry Digest.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on December 10, 2025

Alameda Health System wins equity award for breast cancer screening campaign
December 10, 2025

Alameda Health System wins equity award for breast cancer screening campaign

Indeterminate GlobeNewswire
Polyhydroxyalkanoates (PHA) Market to Reach USD 980 Million by 2035, Growing at 21.5% CAGR from USD 135 Million in 2025
December 10, 2025

Polyhydroxyalkanoates (PHA) Market to Reach USD 980 Million by 2035, Growing at 21.5% CAGR from USD 135 Million in 2025

Indeterminate EIN Presswire
Allsup Helps Individuals With Crohn’s Disease And Ulcerative Colitis Overcome Barriers To SSDI Benefits
December 10, 2025

Allsup Helps Individuals With Crohn’s Disease And Ulcerative Colitis Overcome Barriers To SSDI Benefits

Indeterminate GlobeNewswire
MAIA Takes Aim at a $50B Immunotherapy Market with Breakthrough Telomere-Targeting Approach
December 10, 2025

MAIA Takes Aim at a $50B Immunotherapy Market with Breakthrough Telomere-Targeting Approach

Indeterminate GlobeNewswire
Vietnam Vet cares for wife and wartime nurse
December 10, 2025

Vietnam Vet cares for wife and wartime nurse

Indeterminate GlobeNewswire
Carrick Therapeutics Announces Positive Results from Phase 2 Randomized Trial of Samuraciclib in Combination with Fulvestrant in Patients with Hormone Receptor Positive, HER2 Negative Advanced Breast Cancer
December 10, 2025

Carrick Therapeutics Announces Positive Results from Phase 2 Randomized Trial of Samuraciclib in Combination with Fulvestrant in Patients with Hormone Receptor Positive, HER2 Negative Advanced Breast Cancer

Indeterminate GlobeNewswire
Tiny Health Celebrates 100,000 Tests Milestone, Expands from Baby Gut Health Pioneer to Longevity Innovator
December 10, 2025

Tiny Health Celebrates 100,000 Tests Milestone, Expands from Baby Gut Health Pioneer to Longevity Innovator

Indeterminate GlobeNewswire
Cancer’s 'Dark Matter' Outshines Neoantigens in Landmark Debate
December 10, 2025

Cancer’s 'Dark Matter' Outshines Neoantigens in Landmark Debate

Indeterminate EIN Presswire
Introducing Tryst Fitness, a New Luxury Gym & Wellness Brand
December 10, 2025

Introducing Tryst Fitness, a New Luxury Gym & Wellness Brand

Indeterminate GlobeNewswire
Celiac Disease Clinical Trial Pipeline Gains Momentum: 20+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
December 10, 2025

Celiac Disease Clinical Trial Pipeline Gains Momentum: 20+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

Indeterminate GlobeNewswire
Persephone Biosciences Announces Publication in Cell Host & Microbe Highlighting the Critical Need to Restore Bifidobacterium in the Infant Gut Microbiome
December 10, 2025

Persephone Biosciences Announces Publication in Cell Host & Microbe Highlighting the Critical Need to Restore Bifidobacterium in the Infant Gut Microbiome

Indeterminate GlobeNewswire
Fish Oil Market Supported by a CAGR of 6.5% from 2023 to 2035 | Industry Demand and Opportunities
December 10, 2025

Fish Oil Market Supported by a CAGR of 6.5% from 2023 to 2035 | Industry Demand and Opportunities

Indeterminate EIN Presswire
GENFIT : GNS561 montre une activité antitumorale prometteuse en combinaison thérapeutique
December 10, 2025

GENFIT : GNS561 montre une activité antitumorale prometteuse en combinaison thérapeutique

Indeterminate GlobeNewswire
GENFIT: GNS561 Shows Promising Antitumor Activity in Combination Therapy  
December 10, 2025

GENFIT: GNS561 Shows Promising Antitumor Activity in Combination Therapy  

Indeterminate GlobeNewswire
Valneva Reports Positive Final Phase 2 Antibody Persistence and Safety Results in Children for its Chikungunya Vaccine IXCHIQ®
December 10, 2025

Valneva Reports Positive Final Phase 2 Antibody Persistence and Safety Results in Children for its Chikungunya Vaccine IXCHIQ®

Indeterminate GlobeNewswire
Valneva annonce des résultats finaux de Phase 2 positifs sur la persistance des anticorps et l’innocuité de son vaccin contre le chikungunya IXCHIQ® chez les enfants
December 10, 2025

Valneva annonce des résultats finaux de Phase 2 positifs sur la persistance des anticorps et l’innocuité de son vaccin contre le chikungunya IXCHIQ® chez les enfants

Indeterminate GlobeNewswire
SuspendIt® Is Now a USP Verified Excipient
December 10, 2025

SuspendIt® Is Now a USP Verified Excipient

Indeterminate GlobeNewswire
EmblemHealth Announces New Agreement with the Hospital for Special Surgery
December 10, 2025

EmblemHealth Announces New Agreement with the Hospital for Special Surgery

Indeterminate GlobeNewswire
Cedarhurst Senior Living Fulfills More Than 50 Resident Dreams in 2025 Through Its Dream Come TRUE™ Program
December 10, 2025

Cedarhurst Senior Living Fulfills More Than 50 Resident Dreams in 2025 Through Its Dream Come TRUE™ Program

Indeterminate GlobeNewswire
Priority Partners Opening Two More Free Mini-Pantries in Maryland
December 10, 2025

Priority Partners Opening Two More Free Mini-Pantries in Maryland

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions